Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.


Deal Watch January 2018

Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents covering anti-calcitonin gene-related peptide (CGRP) antibodies and methods - eptinezumab (p3). † ... In exchange for the licence, Alder will withdraw its appeal at the European

The good, the bad and the ugly

The good, the bad and the ugly Pfizer ultimately lost. Patent expiries also led to large declines in CNS sales at Teva (-17%) and Eli Lilly (-27.5%). ... The biggest movers in respiratory were Teva (26%) and Vertex Pharmaceuticals (23.7%).

FDA hands GSK a reprieve by blocking Novartis generic

FDA hands GSK a reprieve by blocking Novartis generic Teva won approval for its AirDuo product last year in the US, providing the same active ingredients as Advair but with a lower dose of salmeterol which means it is not ... At the same time Teva also launched an authorised generic of its own brand to try

The secret of success

The secret of success I am loathe to embarrass those companies, but Teva is one obvious example.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
Emotional Intelligence and Blended Learning in Healthcare